key: cord-1001595-96862vzd
authors: Babu singh, Madhur; Jain, Pallavi; Tomar, Jaya; Kumar, Vinod; Bahadur, Indra; Arya, Dinesh Kumar; Singh, Prashant
title: In Silico study for acyclovir, ganciclovir and its derivatives to fight the COVID-19: Molecular docking, DFT calculations, ADME and td-Molecular dynamics simulations
date: 2022-03-18
journal: Journal of the Indian Chemical Society
DOI: 10.1016/j.jics.2022.100433
sha: c3dbee6f93507523cf5a0b54148b7b72454d0347
doc_id: 1001595
cord_uid: 96862vzd

In the present work, we have designed acyclovir (A), ganciclovir (G) and derivative of hydroxymethyl derivative of ganciclovir (CH2OH of G, that is D) and investigated its potential against the Mpro of nCoV. Density functional theory (DFT) calculations of A, G and D were performed using Gaussian 16 on applying B3LYP under default condition to investigate the delocalization of electron density in their optimized geometry. Free energy of A, G and D were calculated in Hartree per particle. It can be seen that D has the least free energy. Further, the molecular docking of the A, G and D against the Mpro of nCoV was performed using iGemdock and the binding energy for A, G and D were calculated in kcal/mol. It can be seen the D showed effective binding, that is maximum inhibition. For a better understanding of the inhibition of the Mpro of nCoV by A, G and D, temperature dependent molecular dynamics simulations were performed. Various trajectories like RMSD, RMSF, Rg and hydrogen bond were extracted and analyzed. The results of molecular docking corroborate the MD simulations and D could be a promising candidate against Mpro of nCoV.

Drug repurposing is the concept of utilising an FDA-approved drug for a new problem or illness other than the one for which it was originally approved. These drugs save time and money, accelerated their admittance into experimental clinical trials. The process involved the activity based on an experimental or computational approach to develop the new employ of a drug [1] [2] [3] . COVID-19 can cause a range of illness from common cold to severe respiratory syndrome. Coronaviruses (CoV) are a family of encapsulated viruses with single-strained RNA and pathogen. In comparison of previously identified SARS-CoV (2002) and MERS-CoV (2013), SARS-CoV-2 is a more virulent variant [4] [5] [6] [7] . New SARS-CoV has recently received attention worldwide and has been declared as a public health emergency of global concern.

Acyclovir is a well-known antiviral drug mostly used for the treatment of infections due to herpes group viruses and zoster virus. A clinical research report has been published, showing the acyclovir as a promising drug against the infection due to SARS-CoV-2 [8] . F Heidary et al. has done a study of acyclovir as a potent molecule in COVID-19 regimens [9] . Acyclo-GTP is a more efficient inhibitor of viral DNA. Ganciclovir and acyclovir have good efficacy against cytomegalovirus infection [10] . A case report had shown that ganciclovir may act as an effective antiviral drug, even against SARS-CoV-2 [11] . [12] . DFT calculation helps in predicting stability of new compound. It cuts down time and expenses by downsizing the pool of potential candidates for the work. By DFT calculations, the dipole moment and enthalpy of formation can be calculated and these would help us to conclude about the molecule's polarity and behaviour. If the molecule is polar, it would be water-soluble and may be considered as oral drug candidate [13, 14] . The binding affinity between the main protease of nCoV and ligands can be determined using iGemdock 2.1, a computational tool. It is used to investigate the favorable site of the receptor for effective binding of ligand [15] . There is a possibility of van der Waals interaction, hydrogen bonding between the Mpro of nCoV and ligand. Our research group has already provided preliminary information about the docking of acyclovir and its derivatives with Mpro of nCoV [16] . The molecular docking of acyclovir and its derivative against the main protease of SARS-CoV-2 and their binding energy are -89.64 and -96.21 kcal/mol respectively [17] . Absorption, Distribution, Metabolism and Excretion (ADME) is used to know the suitability of a molecule as a potent drug. ADME is used to filter the J o u r n a l P r e -p r o o f compounds to get the leading molecule from high throughput screening (HTS) campaigns. In this work, acyclovir (A), ganciclovir, (G) and hydroxymethyl derivative of ganciclovir (D) are taken for study to inhibit the activity of main protease (Mpro) of novel corona virus (CoV) using molecular docking. Further to make the information reliable and acceptable, molecular dynamics (MD) simulations of Mpro of nCoV with designed molecules at different temperature.

Structures (acyclovir, ganciclovir and hydroxymethyl-ganciclovir) are drawn using chemdraw as in Figure 1 .

Hydroxymethyl-Ganciclovir (D) Figure 1 Structures of A, G and D

The structure of Mpro of nCoV is downloaded from RCSB (PDB:6LU7). Before performing molecular docking, Mpro of nCoV is prepared using chimera. Structure of Mpro of nCoV was opened in chimera followed by removal of ligand, water molecules and heteroatoms were deleted to make docking successful and the structure was saved in PDB format [18] [19] [20] . All J o u r n a l P r e -p r o o f three ligands structures were optimized by applying MM2 forcefield on chemdraw 3D before molecular docking. The docking was performed using iGemdock 2.1 and gives binding energy in kcal/mol as in Table 1 . BIOVIA Discovery Studio Visualizer was used to examine the results and the docked views are given in Figure 2 [21]. as an interface to run the calculations [22, 23] . The parameter applied to perform calculation are optimization plus frequency with B3LYP and the basis set was 6-311G (d,p) at 298 K [24, 25] .

Temperature dependent MD simulation of Mpro of nCoV with A, G and D are performed at various temperatures (290, 300, 310 and 320 K) by using online the web server WebGro (https://simlab.uams.edu/) and it uses GROMACS to perform the calculations [26] [27] [28] [29] [30] . Input G D J o u r n a l P r e -p r o o f parameter used are; forcefield GROMACS9643a, box type triclinic, water model is SPC and salt type is NaCl. Equilibration and MD run parameter used pressure (1bar), number of frames per simulation 1000 and simulation time (100ns). [31, 32] The GlycoBioChem PRODRG2 is an online server that was used to (http://davapc1.bioch.dundee.ac.uk/cgi-bin/prodrg) create a topology of small molecules [33] .

A molecule may be a drug if it has the ability to reach its target location with sufficient concentration and is active in the body for the timespan of biological response. In this work, a free web tool swissADME (http://www.swissadme.ch) has been used to predict the different physiochemical and pharmacokinetic properties of A, G and D. J o u r n a l P r e -p r o o f 

Different thermodynamic parameters such as enthalpy, free energy, optimization energy, thermal energy and zero-point energy were calculated. HOMO can serve as an electron donor [34] and LUMO is the first can act as an electron acceptor [35] . Higher the energy of HOMO indicates more the ability to donate electron density. HUMO, LUMO and optimized geometry of A, G and D are given in Optimization energy and thermal enthalpy are calculated and no significant changes is found as in Table 3 . Free energies are an important parameter for deciding the stability of a compound. It is considered that lesser the free energy of molecule indicates higher stability. [34, [36] [37] [38] Among all the designed compounds, D has the least free energy, that is, -1039.7090 (Hartree per particle) and is considered to be more stable. Dipole moment is also an important parameter for predicting the solubility in aqueous medium. Table 3 shows that G has the highest dipole moment of 10.4241a.u. in all. Various physiochemical descriptors were also determined for the above reported three molecules by DFT calculation as given in Table 4 . ELUMO and EHOMO are significant chemical factors for determining a molecules reactivity and are also applied to derive a range of important chemical reactivity descriptors such as chemical hardness (ɳ), chemical potential (µ), softness(S), electronegativity (χ) are reported in Table 4 Table 4 shows that A has minimum energy gap of -0.1955 and G has maximum of -0.1951. Soft molecules have more polarizability than hard one because they need less energy for excitation. Chemical hardness of A, D and G are found to be -0.0978, -0.0977, -0.0975 respectively. As chemical hardness decreases the stability of compound decreases and polarizability increase. D is more stable and less polarizable as compared to G. Electronegativity defines the tendency of compound to attract the shared pair of electrons and it is the difference of electron affinity and ionization potential.

Obtained data shows that A has highest electronegativity value of -0.12745 and G has minimum of -0.12692. Chemical potential refers to a substance's capacity to generate a chemical reaction in its environment as a result of its own chemical energy or external energy as given in Table 4 . Mathematically chemical potential is negative of electronegativity. The HOMO and LUMO energy are directly proportional to the ionization potential and electron affinity.

Molecular dynamics simulations is used to analyze the dynamic of macromolecular system. It uses the trajectories obtained from MD simulations and gives useful information to investigate the protein-ligand interactions [39, 40] . MD simulations of main protease of nCoV with A, G and D were performed for 100 ns at different temperature. Root mean square deviation is the measure of the average square root of deviation from the mean distance [41, 42] . It provides the conformational stability of macromolecular system due to the binding of ligand into the binding cavity. RMSD values ranges between 0.2 nm to 0.5 nm. It was also found that on increasing temperature the RMSD value increases. Lower temperature favors stabilization of proteinligand complex. During simulations, no loop was seen which indicates less deviation due to binding of the ligands (Figure 4) . 

ADME characteristics are important in the drug development process and always given priority [48] . ADME studies reveals the characteristics of the molecules such as absorption, distribution, metabolism and elimination to make sure for its success as a drug like candidate.

Generally, about 50% of the drugs or candidates fails due to insufficient effectiveness like low bioavailability due to inadequate intestinal absorption and poor metabolic stability [49] [50] [51] [52] .

Lipophilicity is one of the most important criteria to predict the molecule to be a drug. It is also known as partition coefficient between the n-octanol and water (log PO/W) and used to understand the solubility of the molecules or compounds in the water v/s organic solvent [53] .

The partition coefficient is a significant indicator of a substance physical constitution and determines its behavior in various situation. For an effective drug, the value of log PO/W is less than or equal to 5 [54] . Solubility is an important criterion for deciding a molecule to be drug, therefore, log S should be less than 6. According to Lipinski's rule of five, an orally active drug must have: (i) hydrogen bond donor less than or equal to five (ii) hydrogen bond acceptor less than or equal to ten (iii) molecular mass less than 500g/mol (iv) log P values less than 5 [55- Table 5 shows the physiochemical properties of A, G and D. All the studied molecules obey the Lipinski rule of 5. 

Drug likeness is an important criterion for evaluating the behavior of molecule during early stage of drug development. This factor may be regarded as a way to link physicochemical properties of a compound to its biopharmaceutical properties in the human body for oral delivery. Despite the fact that there are several methods for delivery of oral dosages is favored for patient comfort and compliance. At various stages of the discovery process, early assessment of oral bioavailability i.e. the percentage of the dosage that reaches the blood following oral administration is a significant decision-making factor. Bioavailability is influenced by many factors but gastrointestinal absorption is most important. The BBB (Blood-J o u r n a l P r e -p r o o f brain barrier) may be regarded as a shield that protects the brain through a "physical" barrier and a "biochemical" barrier (e.g. P glycoprotein pumping out substrate from CNS tissues). BBB is a system that ensures the consistency of central nervous system environment by allowing brain tissues to interchange nutrients with the outside world. Effective BBB penetration is important for targeting CNS illness, but non-CNS drugs should have restricted BBB penetration due to side effect [59] . Despite the importance of active transport, passive diffusion is the primary route for a drug to reach the brain from the blood. The method for assessing active efflux through biological membrane such as from the gastrointestinal wall to the lumen or from the brain, requires knowledge of compounds that are substrate or non-substrate of the permeability glycoprotein. P-gp has many functions, one of which is to protect the central nervous system from xenobiotics. TPSA is a key characteristic for drug likeness and its value must be smaller than 130 Å. TPSA is considered to be a useful indicator of a compounds ability to transport drug. In Table 6 it is more polarizable. Further, ADME properties of A, G and D were calculated using swissADME to evaluate solubility, bioavailability and potential of molecule to become an effective drug. It has been found that A, G and D followed the Lipinski rule with no violation and falls in an acceptable range for their bioavailability.

Funding There is no source of financial support to perform the work.

Disclosure of potential conflicts of interest and informed consent: I further confirm that the order of authors listed in the manuscript has been approved by all of us. The authors have relevant financial and non-financial interests to disclose. A draft of this was previously submitted to the ResearchSquare platform as a preprint.

Availability of data and material: "The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request." J o u r n a l P r e -p r o o f

COVID-19 treatment by repurposing drugs until the vaccine is in sight

Repurposing antimalarials and other drugs for COVID-19

Drug repurposing and adverse event prediction using high-throughput literature analysis

Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks

A Review of Human Coronaviruses' Receptors: The Host-Cell Targets for the Crown Bearing Viruses

Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection

Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach

Basis Dis. 1866 (2020) 165878

Acyclovir for SARS-CoV-2 : An ClinicalPractice old drug with a new purpose

Acyclovir as a Potential Add-on Therapy in COVID-19 Treatment Regimens, Pharm Sci

Simultaneous determination of acyclovir, ganciclovir, and (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine in human plasma using high-performance liquid chromatography

Immunosuppressive drugs and ganciclovir: two modalities to prevent COVID-19 severity: a case report

Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro)

Stability and reactivity study of bio-molecules brucine and colchicine towards electrophile and nucleophile attacks: Insight from DFT and MD simulations

Exploring the detailed spectroscopic characteristics, chemical and biological activity of two cyanopyrazine-2-carboxamide derivatives using experimental and theoretical tools

Coronavirus spike (S) glycoprotein (2019-ncov) targeted siddha medicin es kabasura kudineer and thonthasura kudineer-in silico evidence for c orona viral drug

Promising Acyclovir and its derivatives to inhibit the protease of SARS-CoV-2: Molecular Docking and Molecular Dynamics simulations

Molecular Docking Study of Acyclovir and Its Derivatives As Potent Inhibitors in Novel Covid-19

A practical guide to large-scale docking

Activity modeling, molecular docking and pharmacokinetic studies of some boron-pleuromutilins as anti-wolbachia agents with potential for treatment of filarial diseases

Protein Data Bank (PDB): The Single Global Macromolecular Structure Archive

Protein Crystallogr. Methods Protoc

iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis

Exploring chemistry

DFT/B3LYP study of tocopherols and chromans antioxidant J o u r n a l P r e -p r o o f action energetics

SIMULATIONS

Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers, SoftwareX

Improved side-chain torsion potentials for the Amber ff99SB protein force field

Implementation of the charmm force field in GROMACS: Analysis of protein stability effects from correction maps, virtual interaction sites, and water models

A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6

Hunting the main protease of SARS-CoV-2 by plitidepsin: Molecular docking and temperature-dependent molecular dynamics simulations

Interactions between main protease of SARS-CoV-2 and testosterone or progesterone using computational approach

{\it PRODRG}: a tool for high-throughput crystallography of protein{--}ligand complexes

An insight of novel eutectic mixture J o u r n a l P r e -p r o o f between thiazolidine-2,4-dione and zinc chloride: Temperature-dependent density functional theory approach

Benchmarks and Reliable DFT Results for Spin Gaps of Small Ligand Fe(II) Complexes

An insight for the interaction of drugs (acyclovir/ganciclovir) with various ionic liquids: DFT calculations and molecular docking

Temperature dependent DFT studies to understand the physiochemical interaction of lithium chloride cluster ions in presence of syringic acid

Stereospecific N-acylation of indoles and corresponding microwave mediated synthesis of pyrazinoindoles using hexafluoroisopropanol

Strength development and deterioration mechanisms of foamed asphalt cold recycled mixture based on MD simulation

Molecular Dynamics Simulation of Protein and Protein-Ligand Complexes BT -Computer-Aided Drug Design

Structural insights into conformational stability of both wild-type and mutant EZH2 receptor

Relaxation Estimation of RMSD in Molecular Dynamics Immunosimulations

How Molecular Size Impacts RMSD Applications in Molecular Dynamics Simulations

Molecular dynamics simulations and analysis for bioinformatics undergraduate students

Understanding the differences of the ligand binding/unbinding pathways between phosphorylated and non-phosphorylated ARH1 using molecular dynamics simulations

Learning probabilistic models of hydrogen bond stability from molecular dynamics simulation trajectories

Hydrogen Bonding in Helical Polypeptides from Molecular Dynamics Simulations and Amide Hydrogen Exchange Analysis: Alamethicin and Melittin in Methanol

Chapter 3 -ADME Principles in Small Molecule Drug Discovery and Development: An Industrial Perspective

Haschek Rousseaux's Handb

ADME of Biologics-What Have We Learned from Small Molecules?

SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules

A Simple, Robust, and Efficient Description of n-Octanol/Water Partition Coefficient for Drug Design Using the GB/SA Approach

Synthesis, Spectroscopic Characterizations of Novel Norcantharimides, Their ADME Properties and Docking Studies Against

ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential

A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases

Prediction of Drug Absorption Using Multivariate Statistics

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Lead-and drug-like compounds: the rule-of-five revolution

Quantitative expression of ADME proteins at the blood-brain barrier

Prediction of the Plasma Concentration Profiles of Orally Administered Drugs in Rats on the Basis of Gastrointestinal Transit Kinetics and Absorbability

Gastrointestinal Transit and Drug Absorption